The inhibitory role of miR-214 in cervical cancer cells through directly targeting mitochondrial transcription factor A (TFAM)

European Journal of Gynaecological Oncology

Volumn 35, Issue 6, 2014, Pages 676-682

  Wen, Z ^a   Lei, Z ^a   Jin An, M ^a   Xue Zhen, L ^a   Xing Nan, Z ^a   Xiu Wen, D ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cervical cancer; Chemotherapy; MiRNA 214; Mitochondrial transcription factor A

Indexed keywords

CISPLATIN; MICRORNA 214; MITOCHONDRIAL TRANSCRIPTION FACTOR A; DNA BINDING PROTEIN; MICRORNA; MIRN214 MICRORNA, HUMAN; MITOCHONDRIAL PROTEIN; TFAM PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER TISSUE; CASKI CELL LINE; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MTT ASSAY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERINE CERVIX CANCER; CELL CYCLE; GENETICS; PATHOLOGY; PHYSIOLOGY; UTERINE CERVICAL NEOPLASMS;

CELL CYCLE; CELL PROLIFERATION; CISPLATIN; DNA-BINDING PROTEINS; FEMALE; HELA CELLS; HUMANS; MICRORNAS; MITOCHONDRIAL PROTEINS; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84925226258     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: 10.12892/ejgo24572014     Document Type: Article

References (25)

1. Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M.: "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008". Int. J. Cancer, 2010, 127, 2893.
2. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D.: "Global cancer statistics". CA Cancer J. Clin., 2011, 61, 69.
3. Uchiumi T., Kang D.: "The role of TFAM-associated proteins in mitochondrial RNA metabolism". Biochim. Biophys. Acta, 2012, 1820, 565.
4. Warda M., Kim H. K., Kim N., Ko K. S., Rhee B. D., Han J.: "A matter of life, death and diseases: mitochondria from a proteomic perspective". Expert Rev. Proteomics, 2013, 10, 97.
5. Cheng, Z., Ristow M.: "Mitochondria and metabolic homeostasis". Antioxid. Redox. Signal, 2013, 19, 240.
6. Guo J, Zheng L, Liu W, Wang X, Wang Z, Wang Z, et al.: "Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer". Cancer Res., 2011, 71, 2978.
7. Correia R. L., Oba-Shinjo S. M., Uno M., Huang N., Marie S. K.: "Mitochondrial DNA depletion and its correlation with TFAM, TFB1M, TFB2M and POLG in human diffusely infiltrating astrocytomas". Mitochondrion, 2011, 11, 48.
8. Li X., Zhang G., Luo F., Ruan J., Huang D., Feng D., et al.: "Identification of aberrantly expressed miRNAs in rectal cancer". Oncol. Rep., 2012, 28, 77.
9. Ambros V.: "The functions of animal microRNAs". Nature, 2004, 431, 350.
10. Deng M., Ye Q., Qin Z., Zheng Y., He W., Tang H., et al.: "miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma". Tumour Biol., 2013, 34, 1793
11. Wang X., Chen J., Li F., Lin Y., Zhang X., Lv Z., Jiang J.: "MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of beta-catenin". Biochem. Biophys. Res. Commun., 2012, 428, 525.
12. Wang, F., Liu M., Li X., Tang H.: "MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells". FEBS Lett., 2013, 587, 488.
13. Qiang R., Wang F., Shi L. Y., Liu M., Chen S., Wan H. Y., et al.: "Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells". Int. J. Biochem. Cell Biol., 2011, 43, 632.
14. Yang Z., Chen S., Luan X., Li Y., Liu M., Li X,. et al.: "MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells". IUBMB Life, 2009, 61, 1075.
15. Fisher D., Krasinska L., Coudreuse D., Novák B.: "Phosphorylation network dynamics in the control of cell cycle transitions". J. Cell. Sci., 2012, 125, 4703.
16. Shylasree, T. S., Bryant A., Athavale R.: "Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma". Cochrane Database Syst. Rev., 2013, 2, CD006246.
17. Bratic, A., Larsson N. G.: "The role of mitochondria in aging". J. Clin. Invest., 2013, 123, 951.
18. Tatarkova Z., Kuka S., Petráš M., Račay P., Lehotski J., Dobrota D., Kaplan P.: "Why mitochondria are excellent targets for cancer therapy". Klin. Onkol., 2012, 25, 421.
19. Kang, D., Kim S. H., Hamasaki N.: "Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions". Mitochondrion, 2007, 7, 39.
20. Asin-Cayuela J., Gustafsson C. M.: "Mitochondrial transcription and its regulation in mammalian cells". Trends Biochem. Sci, 2007, 32, 111.
21. Kim, A. J., Jee H. J., Song N., Kim M., Jeong S. Y., Yun J.: "p21 (WAF (1)/C (1) P (1)) deficiency induces mitochondrial dysfunction in HCT116 colon cancer cells". Biochem. Biophys. Res. Commun., 2013, 430, 653.
22. Sotgia F., Whitaker-Menezes D., Martinez-Outschoorn U. E., Salem A. F., Tsirigos A., Lamb R., et al.: "Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells". Cell Cycle, 2012, 11, 4390.
23. Peng R. Q., Wan H. Y., Li H. F., Liu M., Li X., Tang H.: "MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-alpha-D-galactosamine: polypeptide Nacetylgalactosaminyltransferase 7". J. Biol. Chem., 2012, 287, 14301.
24. Tang L. C., Wang B. Y., Sun S., Zhang J., Jia Z., Lu Y. H., et al.: "Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients". BMC Cancer, 2013, 13, 232.
25. Ushijima, K., Fujiyoshi K., Kawano K., Tsuda N., Nishio S., Eto H., Kamura T.: "Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study". J. Gynecol. Oncol., 2013, 24, 108.